Eli Lilly And Co vs Quanta Services Inc — how do they compare? Eli Lilly And Co trades at $1,179.27 (market cap $1.04T), while Quanta Services Inc trades at $705.94 (market cap $103.03B). The key difference: Eli Lilly And Co is far larger — about 10.1× Quanta Services Inc's market cap, and Eli Lilly And Co pays the higher dividend (0.59%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Quanta Services Inc for 62 Days on average.
| LLY | PWR | |
|---|---|---|
Market Cap | $1.04T | $103.03B |
Volume | 3,064,878 | 977,892 |
Sector | Health | Industrials |
52-Week High | $1.28K | $785.24 |
52-Week Low | $799.57 | $412.21 |
Typical Hold Time | 93 Days | 62 Days |
Enterprise Value | $1.09T | $109.13B |
Dividend Yield | 0.59% | 0.06% |
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company's weight-loss drug portfolio continues to drive exceptional performance, with Q2 2026 EPS of $8.38 beating expectations by 31%. Technical indicators show bullish moving averages while fundamentals reveal impressive 83.4% gross margins and 102.44% ROE. Recent clinical trial successes for next-generation obesity treatments position Lilly for continued market leadership.
LLY presents a compelling growth story with dominant positioning in the expanding obesity/diabetes market, though elevated valuations (P/E 39.26) and regulatory risks require monitoring. Analyst consensus remains strongly bullish with $1,350 price target representing 15% upside. The primary investment thesis centers on pipeline execution and market expansion opportunities, balanced against competitive pressures and valuation concerns.
Quanta Services (PWR) trades at $685.33, down 2.25% on the day, but maintains strong technical momentum with bullish moving averages and support at $684. The company demonstrates robust fundamentals with three consecutive quarterly earnings beats, 15.17% ROE, and accelerating revenue growth from $17.1B in 2022 to $28.5B in 2025. Analyst sentiment remains overwhelmingly positive with 27 buy ratings and a $802.08 consensus price target representing 17% upside potential.
PWR presents a compelling growth story with record $53B backlog and AI infrastructure tailwinds, though elevated valuation multiples (P/E 78.41) and execution risks on large projects warrant caution. The stock's proximity to its pivot point at $684 creates a critical technical level that could determine near-term direction.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →